Currently out of the existing stock ratings of Lyanne Harrison, 3 are a SELL (33.33%), 1 are a HOLD (11.11%), 5 are a BUY (55.56%).

Lyanne Harrison

Work Performance Price Targets & Ratings Chart

Analyst Lyanne Harrison works at BAML with a stock forecast success ratio of 25% fulfilled within 16 days on average.

Lyanne Harrison’s has documented 18 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RMD, ResMed at 17-Oct-2023.

Wall Street Analyst Lyanne Harrison

Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) at 8/3/2020. The price target of $180 was fulfilled within 3 days with a profit of $15.84 (8.09%) receiving and performance score of 26.96.

Average potential price target upside

RMD ResMed RCEL Avita Medical Ltd

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

224

$36.24 (19.30%)

215

17 days ago

5/7 (71.43%)

$34.68 (18.32%)

371

Buy

215

$27.24 (14.51%)

215

22 days ago

7/11 (63.64%)

$18.67 (9.51%)

66

Buy

205

$17.24 (9.18%)

185

2 months 19 days ago

5/11 (45.45%)

$14.1 (7.39%)

88

164

$-23.76 (-12.65%)

158

2 months 24 days ago

4/6 (66.67%)

$-21.88 (-11.77%)

30

Buy

207

$19.24 (10.25%)

2 months 24 days ago

4/5 (80%)

$21.12 (11.36%)

60

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Lyanne Harrison?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?